SCHEMBL6962958

SCHEMBL6962958

Cc1ccc(S(=O)(=O)S)cc1CCc1ccccc1Cl

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 1/20 0.45
TP53 P04637 1/20 0.39
TAAR1 Q96RJ0 3/20 0.39
MAPK1 P28482 1/20 0.39
DAO P14920 2/20 0.38
POLB P06746 3/20 0.38
ALDH1A1 P00352 2/20 0.38
HPGD P15428 1/20 0.38
SLC6A2 P23975 1/20 0.37
SLC6A4 P31645 1/20 0.37
SLC6A3 Q01959 1/20 0.37
AOC3 Q16853 1/20 0.37
LMNA P02545 2/20 0.37
KMT2A Q03164 2/20 0.37
THRB P10828 1/20 0.37
KCNJ6 P48051 1/20 0.37
KCNJ5 P48544 1/20 0.37
KCNJ3 P48549 1/20 0.37
IDO1 P14902 1/20 0.37
RORC P51449 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6604217 0.90 PTGS2 (0.46) PTGS2TP53TAAR1MAPK1DAO
SCHEMBL6962964 0.83 PTGS2 (0.43) PTGS2TP53TAAR1MAPK1DAO
SCHEMBL6604223 0.82 SFRP1 (0.43) POLBALDH1A1LMNAKMT2AMEN1
SCHEMBL6603882 0.77 TDP1 (0.43) POLBALDH1A1LMNAKMT2AMEN1
SCHEMBL6959646 0.77 TDP1 (0.43) POLBALDH1A1LMNAKMT2AMEN1
SCHEMBL6605334 0.74 CA12 (0.43) MAPK1POLBALDH1A1HPGDLMNA
SCHEMBL6605218 0.74 POLB (0.41) PTGS2POLBALDH1A1KMT2AMEN1
SCHEMBL6604221 0.72 PTGS2 (0.44) PTGS2TP53MAPK1DAOPOLB
SCHEMBL6602934 0.71 CYP2C19 (0.45) ALDH1A1
SCHEMBL6967069 0.71 ALDH1A1 (0.47) POLBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0729465-B1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE DAVIS & CO (US) 2003-01-22 EP disclosed
US-6005103-A TREATMENT OF BACTERIAL AND VIRAL INFECTIONS AND DISEASES, INCLUDING AIDS WARNER-LAMBERT COMPANY (US) 1999-12-21 US disclosed
US-5808062-A AIDS THERAPY WARNER-LAMBERT COMPANY (US) 1998-09-15 US disclosed
EP-0729465-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
EP-0729466-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
WO-1995014013-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed
WO-1995014014-A2 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed